10 Health Care Stocks With Whale Alerts In Today's Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth Syndax shares gained support after Guggenheim issued a Buy rating, citing strong Q2 results, Revuforj growth, and long-term profit potential.
2 Incredible Growth Stocks to Buy Hand Over Fist These two healthcare growth stocks could have a lot more room to run.
Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA submission set for Q2 2025.
These stocks are moving in today's after hours session After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26% Instead of seeking a takeover, the company inked a deal worth up to $1.53 billion for its lead asset.
KURA Stock Earnings: Kura Oncology Beats EPS for Q2 2024 KURA stock results show that Kura Oncology beat analyst estimates for earnings per share the second quarter of 2024.
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position.
KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024 KURA stock results show that Kura Oncology missed analyst estimates for earnings per share the first quarter of 2024.
